Aradigm to Present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2015 on February 10
HAYWARD, Calif.--(BUSINESS WIRE)--
Aradigm Corporation (Nasdaq:ARDM) (the "Company") today announced that
President and Chief Executive Officer, Igor Gonda, Ph.D., will present
at the 17th Annual BIO CEO & Investor Conference 2015 on
Tuesday, February 10, 2015, at 2:30 p.m. ET. The event will be held at
the Waldorf-Astoria Hotel in New York, New York.
Interested parties can access a live audio webcast and slide
presentation at www.aradigm.com.
An archived presentation will be available on the Company's Web site for
Aradigm is an emerging specialty pharmaceutical company focused on the
development and commercialization of drugs delivered by inhalation for
the prevention and treatment of severe respiratory diseases. Aradigm has
product candidates addressing the treatment of non-cystic fibrosis
bronchiectasis, cystic fibrosis and prevention of respiratory and other
diseases in tobacco smokers through smoking cessation. Aradigm is also
developing liposomal ciprofloxacin formulations as potential medications
for patients with chronic lung infections with non-tuberculous
mycobacteria (NTM), and for the prevention and treatment of high threat
and bioterrorism infections, such as inhaled tularemia, pneumonic
plague, Q fever and inhaled anthrax.
More information about Aradigm can be found at www.aradigm.com.
Aradigm and the Aradigm Logo are registered trademarks of Aradigm
Nancy Pecota, 510-265-8800
Source: Aradigm Corporation
News Provided by Acquire Media